Literature DB >> 22989843

Postoperative meningitis and epidural abscess due to extended-spectrum β-lactamase-producing Klebsiella pneumoniae: a case report and a review of the literature.

Kenichiro Yaita1, Masanari Komatsu, Yusuke Oshiro, Yukihiro Yamaguchi.   

Abstract

17-year-old man had been involved in a traffic accident. He underwent a bilateral craniotomy with artificial dura mater to remove bilateral acute subdural hematomas. Seven months later, a right cranioplasty was performed using frozen auto-bone, and he developed extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae meningitis and an epidural abscess. Since his general status was poor, we could not remove the foreign body (artificial dura mater). He was successfully treated with meropenem and chronic suppression with oral trimethoprim-sulfamethoxazole. By describing this case and the results of a review of the pertinent literature, we discuss the importance of ESBL-producing Klebsiella pneumoniae meningitis in posttraumatic/postoperative patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22989843     DOI: 10.2169/internalmedicine.51.8068

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Synthesis and biological evaluation of indole core-based derivatives with potent antibacterial activity against resistant bacterial pathogens.

Authors:  Wei Hong; Jingyang Li; Zhe Chang; Xiaoli Tan; Hao Yang; Yifan Ouyang; Yanhui Yang; Sargit Kaur; Ian C Paterson; Yun Fong Ngeow; Hao Wang
Journal:  J Antibiot (Tokyo)       Date:  2017-05-03       Impact factor: 2.649

2.  ESBL Escherichia coli Ventriculitis after Aneurysm Clipping: A Rare and Difficult Therapeutic Challenge.

Authors:  F A Zeiler; J Silvaggio
Journal:  Case Rep Neurol Med       Date:  2015-04-29

3.  Spinal epidural abscess caused by a community acquired extended spectrum beta lactamase producing Klebsiella pneumonia.

Authors:  Vinh Dang; Aarthi Rajkumar
Journal:  IDCases       Date:  2018-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.